Skip to main
  1. Stocks
  2. Pennant Group Inc
  3. Forecast
PNTG

PNTG Stock Forecast & Price Target

PNTG Analyst Ratings

Based on 4 analyst ratings
Buy
Strong Buy 25%
Buy 75%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Pennant Gr is viewed favorably because its core home health and hospice franchise is posting strong organic growth and margin expansion, with 3Q26 revenue of $239.8 million, same-store home health Medicare admissions up 12.0%, hospice ADC up 13.0%, and adjusted EPS of $0.35. The recent ~9% sell-off appears tied to temporary senior living occupancy pressure, as occupancy only fell 60 bps year over year to 81.2% and was concentrated in two integration-heavy markets, while management expects recovery in 4Q. Longer term, the company’s decentralized M&A model, improving Southeast integration, and underappreciated managed care contracting opportunity support further earnings upside, especially as the integration shifts from transition to optimization.

Bears say

Pennant Gr is viewed negatively because integration headwinds in its transitioning assets could force management to halt incremental M&A, undermining a key growth lever after years of rapid expansion. Home Health and Hospice momentum may plateau while labor pressures intensify, driving margin contraction and leaving FY27E EBITDAR 5% to 10% below current estimates, with valuation multiples compressing to 10.7x to 11.4x. The outlook is further weakened by heavy dependence on Medicare-funded reimbursement, senior housing occupancy risk from supply headwinds, and execution risk in turning around underperforming assets and recovering from COVID-driven pressure.

PNTG has been analyzed by 4 analysts, with a consensus rating of Buy. 25% of analysts recommend a Strong Buy, 75% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Pennant Group Inc and is not a guaranteed prediction by Public.com or investment advice.

PNTG Analyst Forecast & Price Prediction

Get the latest PNTG stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis

Start investing in PNTG

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Pennant Group Inc (PNTG) Forecast

Analysts have given PNTG a Buy based on their latest research and market trends.

According to 4 analysts, PNTG has a Buy consensus rating as of Nov 18, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $48.75, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $48.75, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Pennant Group Inc (PNTG)


PNTG Analyst Forecast & Price Prediction

Get the latest PNTG stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis

Start investing in PNTG

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.
Uncover PNTG stock data and trends